What are the renal dosing guidelines for plaque nail treatment in patients with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Renal Dosing for Plaque Nail (Onychomycosis) Treatment

I was unable to locate specific renal dosing guidelines for "plaque nail" as a distinct medication entity in the provided evidence. However, if you are referring to onychomycosis (fungal nail infection) treatment in patients with renal impairment, the following evidence-based recommendations apply:

Systemic Antifungal Agents Requiring Renal Dose Adjustment

Terbinafine

Terbinafine is contraindicated in patients with hepatic impairment and requires caution in renal impairment. 1

  • Standard dosing: 250 mg per day for 12-16 weeks for toenail infections 1
  • Renal impairment consideration: The British Association of Dermatologists guidelines list renal impairment as a contraindication/caution but do not provide specific dose adjustments 1
  • Monitoring: Baseline liver function tests and complete blood count are recommended 1

Fluconazole

Fluconazole requires dose adjustment in renal impairment and may serve as an alternative when terbinafine or itraconazole cannot be tolerated. 1

  • Standard dosing: 150-450 mg per week for at least 6 months for toenail infections 1
  • Renal impairment: Listed as a contraindication/caution requiring adjustment 1
  • Monitoring: Perform baseline liver function tests and full blood count; monitor liver function in high-dose or prolonged therapy 1

Itraconazole

Itraconazole is first-line treatment for dermatophyte onychomycosis but requires monitoring in patients with hepatotoxicity risk. 1

  • Standard dosing: 200 mg per day for 12 weeks continuously, or pulse therapy at 400 mg per day for 1 week per month (3 pulses for toenails) 1
  • Renal considerations: While not specifically contraindicated in renal disease, hepatic function monitoring is essential 1

Griseofulvin

Griseofulvin is contraindicated in liver impairment and has lower efficacy compared to terbinafine and itraconazole. 1

  • Standard dosing: 500-1000 mg per day for 12-18 months for toenail infection 1
  • Renal considerations: No specific renal dose adjustment mentioned, but avoid in hepatic impairment 1

Topical Therapy (No Renal Adjustment Required)

Topical antifungals do not require renal dose adjustment and are useful alternatives when systemic therapy is contraindicated. 1

  • Amorolfine 5% lacquer: Applied once or twice weekly for 6-12 months 1
  • Ciclopirox 8% lacquer: Applied once daily for up to 48 weeks 1
  • Tioconazole 28% solution: Applied twice daily for 6-12 months 1

General Principles for Renal Dosing

For medications requiring renal adjustment, reduce dosing frequency rather than dose amount for concentration-dependent drugs to maintain efficacy. 1, 2

  • Maintain the milligram dose at 12-15 mg/kg per dose while extending the interval to two or three times weekly 1, 2
  • Serum drug concentrations should be monitored to avoid toxicity in patients with severe renal impairment 1, 2
  • Smaller doses may reduce drug efficacy, so maintaining dose amount while extending intervals is preferred 2

Clinical Approach

In patients with chronic kidney disease requiring onychomycosis treatment:

  1. Assess renal function using creatinine clearance or glomerular filtration rate 3
  2. Consider topical therapy first if systemic contraindications exist 1
  3. If systemic therapy needed: Choose fluconazole or itraconazole with appropriate monitoring, avoiding terbinafine if significant renal impairment present 1
  4. Monitor closely for drug accumulation and adverse effects 3

Important Caveats

  • Drug dosing errors are common in patients with renal impairment and can cause adverse effects 3
  • Chronic kidney disease affects drug absorption, distribution, metabolism, and clearance 3
  • Nephrotoxic drugs should be avoided entirely in patients with renal impairment 1
  • Baseline and regular monitoring of renal parameters are necessary when using potentially nephrotoxic medications 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dosage Adjustment for Severe Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.